|
|
||||||||
J Thorac Cardiovasc Surg 2003;125:739
© 2003 The American Association for Thoracic Surgery
Letters to the Editor |
Department of Cardiac Surgery, Royal Sussex County Hospital, Brighton, United Kingdoma
Department of Cardiac Surgery, University of Glasgow, Royal Infirmary, Glasgow, United Kingdomb
Department of Medicine, Manchester Royal Infirmary, Manchester, United Kingdomc
| The first 20% of the full text of this article appears below. |
To the Editor:
Bizzari and associates
1 studied clinical events and potential bleeding complications in a group of patients who had undergone emergency or urgent cardiac surgery after treatment with tirofiban hydrochloride. They observed that patients treated with tirobifan had a smaller decrease in platelet count during cardiopulmonary bypass; other platelet suppressants have similar
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |